Safety Extension Study of TRO19622 in ALS

Summary

The purpose of the assay is to assess the safety of TRO19622 330 mg QD as add-on therapy to riluzole 50 mg bid in the treatment of patients suffering from ALS, after completion of the preceding clinical trial (TRO19622 CL E Q 1015-1) in an open label extension.

Timeline

Start

2010-10

Primary completion

2012-03

Completion

2012-03

Drugs

Indications